We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events (COAGFAII)

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: October 20, 2010
Last Update Posted: October 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Ministry of Health, France
Information provided by:
Hopital Lariboisière
The primary aim of the study was to assess whether D-Dimer level at entry or an increase of D-Dimer level during the follow-up could predict the occurrence of subsequent cardiovascular events in patients with atrial fibrillation.

Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Place Des D-dimères Dans la Prise en Charge Des Patients en Fibrillation Auriculaire : Evaluation de la Valeur prédictive Des D-dimères Sur la Survenue d'événements Thromboemboliques

Resource links provided by NLM:

Further study details as provided by Hopital Lariboisière:

Biospecimen Retention:   Samples Without DNA
No biospecimens are to be retained

Enrollment: 425
Study Start Date: January 2001
Study Completion Date: July 2007
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:
Patients will be followed-up every 4 months with clinical assessment and D-dimer blinded measurement.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with atrial fibrillation encountered in usual care

Inclusion Criteria:

  • atrial fibrillation

Exclusion Criteria:

  • follow-up not possible, poor prognosis within 3 months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01224574

Paris, France
Sponsors and Collaborators
Hopital Lariboisière
Ministry of Health, France
Principal Investigator: Isabelle Mahé, MD,PhD Hopital Lariboisière
  More Information

Responsible Party: Projet Hospitalier de Recherche Clinique Régional, Direction de la Recherche Clinique
ClinicalTrials.gov Identifier: NCT01224574     History of Changes
Other Study ID Numbers: AOR 01 029
First Submitted: September 13, 2010
First Posted: October 20, 2010
Last Update Posted: October 20, 2010
Last Verified: September 2010

Keywords provided by Hopital Lariboisière:
atrial fribrillation, cardiovascular events, aging, D-dimer

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes